Found: 2
Select item for more details and to access through your institution.
p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1199-7
- By:
- Publication type:
- Article
Case report of a 65-year-old man with biatrial metastatic localisation from poorly differentiated cutaneous squamous cell carcinoma.
- Published in:
- Ecancermedicalscience, 2019, v. 13, n. 962-995, p. 1, doi. 10.3332/ecancer.2019.977
- By:
- Publication type:
- Article